Researchers have screened thousands of approved drugs against a network of 2,358 longevity-linked genes, producing a shortlist of compounds that may slow biological aging without new drug development.

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

Repurposing and repositioning have gained considerable attention from a range of stakeholders, including NIH, academic institutions, pharmaceutical companies, and even some technology companies, for ...

Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States topped $722 billion, a trend that's expected to continue. Yet, nearly 30% ...

Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than those in the pharmaceutical industry. This "hidden" research system, which ...

A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom the vaccine is less effective, such as older adults ...

Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study. A combination treatment incorporating three existing drugs -- tamsulosin, metoprolol and ...

Drug repurposing — the identification of new therapeutic indications for approved drugs or clinical-stage candidates — offers one of the most efficient strategies to deliver new treatments to patients ...

Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...